The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia

Ahmet Emre Eskazan; Tugrul Elverdi; Fevzi Firat Yalniz; Ayse Salihoglu; Muhlis Cem Ar; Seniz Ongoren Aydin; Zafer Baslar; Yildiz Aydin; Nukhet Tuzuner; Ugur Ozbek; Teoman Soysal

doi:10.3109/10428194.2014.905774

The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia

Ahmet Emre Eskazan, Tugrul Elverdi, Fevzi Firat Yalniz, Ayse Salihoglu, Muhlis Cem Ar, Seniz Ongoren Aydin, Zafer Baslar, Yildiz Aydin, Nukhet Tuzuner, Ugur Ozbek, Teoman Soysal

Research output: Contribution to journal › Letter › peer-review

21 Scopus citations

Original language	English
Pages (from-to)	2935-2937
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	55
Issue number	12
DOIs	https://doi.org/10.3109/10428194.2014.905774
State	Published - Dec 1 2014

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/10428194.2014.905774

Cite this

@article{39352b71691d4a67bccb4fadbdef9183,

title = "The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia",

author = "Eskazan, \{Ahmet Emre\} and Tugrul Elverdi and Yalniz, \{Fevzi Firat\} and Ayse Salihoglu and Ar, \{Muhlis Cem\} and \{Ongoren Aydin\}, Seniz and Zafer Baslar and Yildiz Aydin and Nukhet Tuzuner and Ugur Ozbek and Teoman Soysal",

year = "2014",

month = dec,

day = "1",

doi = "10.3109/10428194.2014.905774",

language = "English",

volume = "55",

pages = "2935--2937",

number = "12",

}

TY - JOUR

T1 - The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia

AU - Eskazan, Ahmet Emre

AU - Elverdi, Tugrul

AU - Yalniz, Fevzi Firat

AU - Salihoglu, Ayse

AU - Ar, Muhlis Cem

AU - Ongoren Aydin, Seniz

AU - Baslar, Zafer

AU - Aydin, Yildiz

AU - Tuzuner, Nukhet

AU - Ozbek, Ugur

AU - Soysal, Teoman

PY - 2014/12/1

Y1 - 2014/12/1

UR - https://www.scopus.com/pages/publications/84908871455

UR - https://www.scopus.com/inward/citedby.url?scp=84908871455&partnerID=8YFLogxK

U2 - 10.3109/10428194.2014.905774

DO - 10.3109/10428194.2014.905774

M3 - Letter

C2 - 24650055

AN - SCOPUS:84908871455

SN - 1042-8194

VL - 55

SP - 2935

EP - 2937

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 12

ER -

The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this